Global Nanoparticle Drug Delivery Systems Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 22-Jan-2022
No. of pages: 156
Inquire Before Buying

Market Analysis and Insights: Global Nanoparticle Drug Delivery Systems Market

The global Nanoparticle Drug Delivery Systems market size is projected to reach US$ 8103 million by 2027, from US$ 4089 million in 2020, at a CAGR of 10% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nanoparticle Drug Delivery Systems market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nanoparticle Drug Delivery Systems market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nanoparticle Drug Delivery Systems market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nanoparticle Drug Delivery Systems market.

Global Nanoparticle Drug Delivery Systems Scope and Market Size

Nanoparticle Drug Delivery Systems market is segmented by players, region (country), by Type, and By Application. Players, stakeholders, and other participants in the global Nanoparticle Drug Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and By Application in terms of revenue and forecast for the period 2016-2027.

By Company-

- Johnson & Johnson

- Sun Pharmaceutical

- CSPC

- Kinyond

- Teva

- Fudan-Zhangjiang

- Zydus Cadila

- TTY Biopharma

- Pacira

- Luye Pharma

- Leadiant Biosciences

- Ipsen

- Sayre Therapeutics

- Jazz

- Alnylam

- Bausch Health

- Acrotech Biopharma

- Takeda

- Chiesi Farmaceutici

- Gilead Sciences

Segment by Type

- Liposomes Drugs

- Lipid Nanoparticle Drugs

Segment by Application

- Hospital

- Retail Pharmacy

- Other

By Region

- North America

- United States

- Canada

- Mexico

- Asia-Pacific

- China

- Japan

- South Korea

- Southeast Asia

- India

- Australia

- Rest of Asia

- Europe

- Germany

- France

- U.K.

- Italy

- Russia

- Rest of Europe

- South America

- Brazil

- Rest of South America

- Middle East & Africa

- Middle East

- Africa

Global Nanoparticle Drug Delivery Systems Market Size, Status and Forecast 2021-2027

Table of Contents
1 REPORT OVERVIEW 1
1.1 Study Scope 1
1.2 Market Analysis by Type 1
1.2.1 Global Nanoparticle Drug Delivery Systems Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1
1.2.2 Liposomes Drugs 3
1.2.3 Lipid Nanoparticle Drugs 4
1.3 Market by Application 5
1.3.1 Global Nanoparticle Drug Delivery Systems Market Share by Application: 2016 VS 2021 VS 2027 6
1.3.2 Hospital 6
1.3.3 Retail Pharmacy 7
1.4 Study Objectives 8
1.5 Years Considered 8
2 GLOBAL GROWTH TRENDS 9
2.1 Global Nanoparticle Drug Delivery Systems Market Perspective (2016-2027) 9
2.2 Nanoparticle Drug Delivery Systems Growth Trends by Regions 10
2.2.1 Nanoparticle Drug Delivery Systems Market Size by Regions: 2016 VS 2021 VS 2027 10
2.2.2 Nanoparticle Drug Delivery Systems Historic Market Size by Regions (2016-2021) 12
2.2.3 Nanoparticle Drug Delivery Systems Forecasted Market Size by Regions (2022-2027) 12
2.3 Nanoparticle Drug Delivery Systems Industry Dynamic 13
2.3.1 Nanoparticle Drug Delivery Systems Market Trends 13
2.3.2 Nanoparticle Drug Delivery Systems Market Drivers 17
2.3.3 Nanoparticle Drug Delivery Systems Market Challenges 18
2.3.4 Nanoparticle Drug Delivery Systems Market Restraints 18
3 COMPETITION LANDSCAPE BY KEY PLAYERS 21
3.1 Global Top Nanoparticle Drug Delivery Systems Players by Revenue 21
3.1.1 Global Top Nanoparticle Drug Delivery Systems Players by Revenue (2019-2021) 21
3.1.2 Global Nanoparticle Drug Delivery Systems Revenue Market Share by Players (2019-2021) 22
3.2 Global Nanoparticle Drug Delivery Systems by Company Type (Tier 1, Tier 2, and Tier 3) 23
3.3 Players Covered: Ranking by Nanoparticle Drug Delivery Systems Revenue 24
3.4 Global Nanoparticle Drug Delivery Systems Market Concentration Ratio 25
3.4.1 Global Nanoparticle Drug Delivery Systems Market Concentration Ratio (CR5 and HHI) 25
3.4.2 Global Top 5 Companies by Nanoparticle Drug Delivery Systems Revenue in 2020 27
3.4.3 Global Top 10 Companies by Nanoparticle Drug Delivery Systems Revenue in 2020 28
3.5 Nanoparticle Drug Delivery Systems Key Players Head office and Area Served 28
3.6 Key Players Nanoparticle Drug Delivery Systems Product Solution and Service 29
3.7 Founded Date of Nanoparticle Drug Delivery Systems Players 30
3.8 Mergers & Acquisitions, Expansion Plans 31
4 NANOPARTICLE DRUG DELIVERY SYSTEMS BREAKDOWN DATA BY TYPE 32
4.1 Global Nanoparticle Drug Delivery Systems Historic Market Size by Type (2016-2021) 32
4.2 Global Nanoparticle Drug Delivery Systems Forecasted Market Size by Type (2022-2027) 33
5 NANOPARTICLE DRUG DELIVERY SYSTEMS BREAKDOWN DATA BY APPLICATION 35
5.1 Global Nanoparticle Drug Delivery Systems Historic Market Size by Application (2016-2021) 35
5.2 Global Nanoparticle Drug Delivery Systems Forecasted Market Size by Application (2022-2027) 36
6 NORTH AMERICA 37
6.1 North America Nanoparticle Drug Delivery Systems Market Size (2016-2027) 37
6.2 North America Nanoparticle Drug Delivery Systems Market Size by Type 37
6.2.1 North America Nanoparticle Drug Delivery Systems Market Size by Type (2016-2021) 37
6.2.2 North America Nanoparticle Drug Delivery Systems Market Size by Type (2022-2027) 38
6.2.3 North America Nanoparticle Drug Delivery Systems Market Size by Type (2016-2027) 38
6.3 North America Nanoparticle Drug Delivery Systems Market Size by Application 39
6.3.1 North America Nanoparticle Drug Delivery Systems Market Size by Application (2016-2021) 39
6.3.2 North America Nanoparticle Drug Delivery Systems Market Size by Application (2022-2027) 39
6.3.3 North America Nanoparticle Drug Delivery Systems Market Size by Application (2016-2027) 40
6.4 North America Nanoparticle Drug Delivery Systems Market Size by Country 40
6.4.1 North America Nanoparticle Drug Delivery Systems Market Size by Country (2016-2021) 40
6.4.2 North America Nanoparticle Drug Delivery Systems Market Size by Country (2022-2027) 41
6.4.3 United States 42
6.4.4 Canada 43
6.4.5 Mexico 44
7 EUROPE 45
7.1 Europe Nanoparticle Drug Delivery Systems Market Size (2016-2027) 45
7.2 Europe Nanoparticle Drug Delivery Systems Market Size by Type 45
7.2.1 Europe Nanoparticle Drug Delivery Systems Market Size by Type (2016-2021) 45
7.2.2 Europe Nanoparticle Drug Delivery Systems Market Size by Type (2022-2027) 46
7.2.3 Europe Nanoparticle Drug Delivery Systems Market Size by Type (2016-2027) 46
7.3 Europe Nanoparticle Drug Delivery Systems Market Size by Application 47
7.3.1 Europe Nanoparticle Drug Delivery Systems Market Size by Application (2016-2021) 47
7.3.2 Europe Nanoparticle Drug Delivery Systems Market Size by Application (2022-2027) 47
7.3.3 Europe Nanoparticle Drug Delivery Systems Market Size by Application (2016-2027) 48
7.4 Europe Nanoparticle Drug Delivery Systems Market Size by Country 48
7.4.1 Europe Nanoparticle Drug Delivery Systems Market Size by Country (2016-2021) 48
7.4.2 Europe Nanoparticle Drug Delivery Systems Market Size by Country (2022-2027) 49
7.4.3 Germany 50
7.4.4 France 51
7.4.5 U.K. 52
7.4.6 Italy 53
7.4.7 Russia 54
8 ASIA-PACIFIC 55
8.1 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size (2016-2027) 55
8.2 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Type 55
8.2.1 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Type (2016-2021) 55
8.2.2 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Type (2022-2027) 56
8.2.3 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Type (2016-2027) 56
8.3 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Application 57
8.3.1 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Application (2016-2021) 57
8.3.2 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Application (2022-2027) 57
8.3.3 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Application (2016-2027) 58
8.4 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Region 58
8.4.1 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Region (2016-2021) 58
8.4.2 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Region (2022-2027) 59
8.4.3 China 60
8.4.4 Japan 61
8.4.5 South Korea 62
8.4.6 Southeast Asia 63
8.4.7 India 64
8.4.8 Australia 65
9 SOUTH AMERICA 66
9.1 South America Nanoparticle Drug Delivery Systems Market Size (2016-2027) 66
9.2 South America Nanoparticle Drug Delivery Systems Market Size by Type 66
9.2.1 South America Nanoparticle Drug Delivery Systems Market Size by Type (2016-2021) 66
9.2.2 South America Nanoparticle Drug Delivery Systems Market Size by Type (2022-2027) 67
9.2.3 South America Nanoparticle Drug Delivery Systems Market Size by Type (2016-2027) 67
9.3 South America Nanoparticle Drug Delivery Systems Market Size by Application 68
9.3.1 South America Nanoparticle Drug Delivery Systems Market Size by Application (2016-2021) 68
9.3.2 South America Nanoparticle Drug Delivery Systems Market Size by Application (2022-2027) 68
9.3.3 South America Nanoparticle Drug Delivery Systems Market Size by Application (2016-2027) 69
9.4 South America Nanoparticle Drug Delivery Systems Market Size by Country 69
9.4.1 South America Nanoparticle Drug Delivery Systems Market Size by Country (2016-2021) 69
9.4.2 South America Nanoparticle Drug Delivery Systems Market Size by Country (2022-2027) 70
9.4.3 Brazil 71
10 MIDDLE EAST & AFRICA 72
10.1 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size (2016-2027) 72
10.2 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Type 72
10.2.1 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Type (2016-2021) 72
10.2.2 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Type (2022-2027) 73
10.2.3 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Type (2016-2027) 73
10.3 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Application 74
10.3.1 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Application (2016-2021) 74
10.3.2 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Application (2022-2027) 74
10.3.3 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Application (2016-2027) 75
10.4 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Country 75
10.4.1 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Country (2016-2021) 75
10.4.2 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Country (2022-2027) 76
10.4.3 Middle East 77
10.4.4 Africa 77
11 KEY PLAYERS PROFILES 78
11.1 Johnson & Johnson 78
11.1.1 Johnson & Johnson Company Details 78
11.1.2 Johnson & Johnson Business Overview 78
11.1.3 Johnson & Johnson Nanoparticle Drug Delivery Systems Introduction 79
11.1.4 Johnson & Johnson Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 80
11.1.5 Johnson & Johnson Recent Development 81
11.2 Sun Pharmaceutical 81
11.2.1 Sun Pharmaceutical Company Details 81
11.2.2 Sun Pharmaceutical Business Overview 82
11.2.3 Sun Pharmaceutical Nanoparticle Drug Delivery Systems Introduction 82
11.2.4 Sun Pharmaceutical Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 83
11.3 CSPC 83
11.3.1 CSPC Company Details 83
11.3.2 CSPC Business Overview 84
11.3.3 CSPC Nanoparticle Drug Delivery Systems Introduction 85
11.3.4 CSPC Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 85
11.4 Kinyond 86
11.4.1 Kinyond Company Details 86
11.4.2 Kinyond Business Overview 86
11.4.3 Kinyond Nanoparticle Drug Delivery Systems Introduction 86
11.4.4 Kinyond Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 87
11.5 Teva 88
11.5.1 Teva Company Details 88
11.5.2 Teva Business Overview 88
11.5.3 Teva Nanoparticle Drug Delivery Systems Introduction 89
11.5.4 Teva Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 89
11.5.5 Teva Recent Development 89
11.6 Fudan-Zhangjiang 90
11.6.1 Fudan-Zhangjiang Company Details 90
11.6.2 Fudan-Zhangjiang Business Overview 91
11.6.3 Fudan-Zhangjiang Nanoparticle Drug Delivery Systems Introduction 91
11.6.4 Fudan-Zhangjiang Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 92
11.7 Zydus Cadila 93
11.7.1 Zydus Cadila Company Details 93
11.7.2 Zydus Cadila Business Overview 93
11.7.3 Zydus Cadila Nanoparticle Drug Delivery Systems Introduction 94
11.7.4 Zydus Cadila Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 94
11.8 TTY Biopharma 94
11.8.1 TTY Biopharma Company Details 94
11.8.2 TTY Biopharma Business Overview 95
11.8.3 TTY Biopharma Nanoparticle Drug Delivery Systems Introduction 95
11.8.4 TTY Biopharma Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 96
11.9 Pacira 96
11.9.1 Pacira Company Details 96
11.9.2 Pacira Business Overview 97
11.9.3 Pacira Nanoparticle Drug Delivery Systems Introduction 97
11.9.4 Pacira Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 98
11.9.5 Pacira Recent Development 98
11.10 Luye Pharma 100
11.10.1 Luye Pharma Company Details 100
11.10.2 Luye Pharma Business Overview 100
11.10.3 Luye Pharma Nanoparticle Drug Delivery Systems Introduction 101
11.10.4 Luye Pharma Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 101
11.11 Leadiant Biosciences 102
11.11.1 Leadiant Biosciences Company Details 102
11.11.2 Leadiant Biosciences Business Overview 102
11.11.3 Leadiant Biosciences Nanoparticle Drug Delivery Systems Introduction 103
11.11.4 Leadiant Biosciences Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 103
11.11.5 Leadiant Biosciences Recent Development 103
11.12 Ipsen 104
11.12.1 Ipsen Company Details 104
11.12.2 Ipsen Business Overview 105
11.12.3 Ipsen Nanoparticle Drug Delivery Systems Introduction 105
11.12.4 Ipsen Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 106
11.12.5 Ipsen Recent Development 106
11.13 Sayre Therapeutics 108
11.13.1 Sayre Therapeutics Company Details 108
11.13.2 Sayre Therapeutics Business Overview 108
11.13.3 Sayre Therapeutics Nanoparticle Drug Delivery Systems Introduction 109
11.13.4 Sayre Therapeutics Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 110
11.13.5 Sayre Therapeutics Recent Development 110
11.14 Jazz 111
11.14.1 Jazz Company Details 111
11.14.2 Jazz Business Overview 111
11.14.3 Jazz Nanoparticle Drug Delivery Systems Introduction 112
11.14.4 Jazz Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 112
11.14.5 Jazz Recent Development 112
11.15 Alnylam 114
11.15.1 Alnylam Company Details 114
11.15.2 Alnylam Business Overview 114
11.15.3 Alnylam Nanoparticle Drug Delivery Systems Introduction 115
11.15.4 Alnylam Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 115
11.15.5 Alnylam Recent Development 116
11.16 Bausch Health 117
11.16.1 Bausch Health Company Details 117
11.16.2 Bausch Health Business Overview 118
11.16.3 Bausch Health Nanoparticle Drug Delivery Systems Introduction 118
11.16.4 Bausch Health Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 119
11.16.5 Bausch Health Recent Development 119
11.17 Acrotech Biopharma 120
11.17.1 Acrotech Biopharma Company Details 120
11.17.2 Acrotech Biopharma Business Overview 120
11.17.3 Acrotech Biopharma Nanoparticle Drug Delivery Systems Introduction 121
11.17.4 Acrotech Biopharma Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 121
11.17.5 Acrotech Biopharma Recent Development 122
11.18 Takeda 123
11.18.1 Takeda Company Details 123
11.18.2 Takeda Business Overview 123
11.18.3 Takeda Nanoparticle Drug Delivery Systems Introduction 124
11.18.4 Takeda Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 124
11.18.5 Takeda Recent Development 124
11.19 Chiesi Farmaceutici 126
11.19.1 Chiesi Farmaceutici Company Details 126
11.19.2 Chiesi Farmaceutici Business Overview 127
11.19.3 Chiesi Farmaceutici Nanoparticle Drug Delivery Systems Introduction 127
11.19.4 Chiesi Farmaceutici Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 127
11.20 Gilead Sciences 128
11.20.1 Gilead Sciences Company Details 128
11.20.2 Gilead Sciences Business Overview 128
11.20.3 Gilead Sciences Nanoparticle Drug Delivery Systems Introduction 129
11.20.4 Gilead Sciences Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 129
11.20.5 Gilead Sciences Recent Development 130
12 ANALYST'S VIEWPOINTS/CONCLUSIONS 131
13 APPENDIX 132
13.1 Research Methodology 132
13.1.1 Methodology/Research Approach 132
13.1.2 Data Source 135
13.2 Disclaimer 138
13.3 Author Details 138
List of Tables
Table 1. Global Nanoparticle Drug Delivery Systems Market Size Growth Rate by Type (US$ Million): 2016 VS 2021 VS 2027 2
Table 2. Key Players of Liposomes Drugs 4
Table 3. Key Players of Lipid Nanoparticle Drugs 5
Table 4. Global Nanoparticle Drug Delivery Systems Market Size Growth by Application (US$ Million): 2016 VS 2020 VS 2027 6
Table 5. Global Nanoparticle Drug Delivery Systems Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 10
Table 6. Global Nanoparticle Drug Delivery Systems Market Size by Regions (2016-2021) & (US$ Million) 12
Table 7. Global Nanoparticle Drug Delivery Systems Market Share by Regions (2016-2021) 12
Table 8. Global Nanoparticle Drug Delivery Systems Forecasted Market Size by Regions (2022-2027) & (US$ Million) 12
Table 9. Global Nanoparticle Drug Delivery Systems Market Share by Regions (2022-2027) 13
Table 10. Nanoparticle Drug Delivery Systems Market Drivers 17
Table 11. Nanoparticle Drug Delivery Systems Market Challenges 18
Table 12. Global Nanoparticle Drug Delivery Systems Revenue by Players (2019-2021) & (US$ Million) 21
Table 13. Global Nanoparticle Drug Delivery Systems Market Share by Players (2019-2021) 22
Table 14. Global Top Nanoparticle Drug Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanoparticle Drug Delivery Systems as of 2020) 24
Table 15. Ranking of Global Top Nanoparticle Drug Delivery Systems Companies by Revenue (US$ Million) in 2020 25
Table 16. Global 5 Largest Players Market Share by Nanoparticle Drug Delivery Systems Revenue (CR5 and HHI) & (2019-2021) 26
Table 17. Key Players Headquarters and Area Served 28
Table 18. Key Players Nanoparticle Drug Delivery Systems Product Solution and Service 29
Table 19. Founded Date of Nanoparticle Drug Delivery Systems Players 30
Table 20. Mergers & Acquisitions, Expansion Plans 31
Table 21. Global Nanoparticle Drug Delivery Systems Market Size by Type (2016-2021) & (US$ Million) 32
Table 22. Global Nanoparticle Drug Delivery Systems Revenue Market Share by Type (2016-2021) 32
Table 23. Global Nanoparticle Drug Delivery Systems Forecasted Market Size by Type (2022-2027) & (US$ Million) 33
Table 24. Global Nanoparticle Drug Delivery Systems Revenue Market Share by Type (2022-2027) 33
Table 25. Global Nanoparticle Drug Delivery Systems Market Size by Application (2016-2021) & (US$ Million) 35
Table 26. Global Nanoparticle Drug Delivery Systems Revenue Market Share by Application (2016-2021) 35
Table 27. Global Nanoparticle Drug Delivery Systems Forecasted Market Size by Application (2022-2027) & (US$ Million) 36
Table 28. Global Nanoparticle Drug Delivery Systems Revenue Market Share by Application (2022-2027) 36
Table 29. North America Nanoparticle Drug Delivery Systems Market Size by Type (2016-2021) & (US$ Million) 37
Table 30. North America Nanoparticle Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million) 38
Table 31. North America Nanoparticle Drug Delivery Systems Market Size by Application (2016-2021) & (US$ Million) 39
Table 32. North America Nanoparticle Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million) 39
Table 33. North America Nanoparticle Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million) 40
Table 34. North America Nanoparticle Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million) 41
Table 35. Europe Nanoparticle Drug Delivery Systems Market Size by Type (2016-2021) & (US$ Million) 45
Table 36. Europe Nanoparticle Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million) 46
Table 37. Europe Nanoparticle Drug Delivery Systems Market Size by Application (2016-2021) & (US$ Million) 47
Table 38. Europe Nanoparticle Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million) 47
Table 39. Europe Nanoparticle Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million) 48
Table 40. Europe Nanoparticle Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million) 49
Table 41. Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Type (2016-2021) & (US$ Million) 55
Table 42. Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million) 56
Table 43. Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Application (2016-2021) & (US$ Million) 57
Table 44. Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million) 57
Table 45. Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Region (2016-2021) & (US$ Million) 58
Table 46. Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Region (2022-2027) & (US$ Million) 59
Table 47. South America Nanoparticle Drug Delivery Systems Market Size by Type (2016-2021) & (US$ Million) 66
Table 48. South America Nanoparticle Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million) 67
Table 49. South America Nanoparticle Drug Delivery Systems Market Size by Application (2016-2021) & (US$ Million) 68
Table 50. South America Nanoparticle Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million) 68
Table 51. South America Nanoparticle Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million) 69
Table 52. South America Nanoparticle Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million) 70
Table 53. Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Type (2016-2021) & (US$ Million) 72
Table 54. Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million) 73
Table 55. Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Application (2016-2021) & (US$ Million) 74
Table 56. Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million) 74
Table 57. Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million) 75
Table 58. Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million) 76
Table 59. Johnson & Johnson Company Details 78
Table 60. Johnson & Johnson Business Overview 78
Table 61. Johnson & Johnson Nanoparticle Drug Delivery Systems Product 79
Table 62. Johnson & Johnson Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million) 80
Table 63. Johnson & Johnson Recent Development 81
Table 64. Sun Pharmaceutical Company Details 81
Table 65. Sun Pharmaceutical Business Overview 82
Table 66. Sun Pharmaceutical Nanoparticle Drug Delivery Systems Product 82
Table 67. Sun Pharmaceutical Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million) 83
Table 68. CSPC Company Details 83
Table 69. CSPC Business Overview 84
Table 70. CSPC Nanoparticle Drug Delivery Systems Product 85
Table 71. CSPC Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million) 85
Table 72. Kinyond Company Details 86
Table 73. Kinyond Business Overview 86
Table 74. Kinyond Nanoparticle Drug Delivery Systems Product 86
Table 75. Kinyond Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million) 87
Table 76. Teva Company Details 88
Table 77. Teva Business Overview 88
Table 78. Teva Nanoparticle Drug Delivery Systems Product 89
Table 79. Teva Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million) 89
Table 80. Teva Recent Development 89
Table 81. Fudan-Zhangjiang Company Details 90
Table 82. Fudan-Zhangjiang Business Overview 91
Table 83. Fudan-Zhangjiang Nanoparticle Drug Delivery Systems Product 91
Table 84. Fudan-Zhangjiang Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million) 92
Table 85. Zydus Cadila Company Details 93
Table 86. Zydus Cadila Business Overview 93
Table 87. Zydus Cadila Nanoparticle Drug Delivery Systems Product 94
Table 88. Zydus Cadila Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million) 94
Table 89. TTY Biopharma Company Details 94
Table 90. TTY Biopharma Business Overview 95
Table 91. TTY Biopharma Nanoparticle Drug Delivery Systems Product 95
Table 92. TTY Biopharma Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million) 96
Table 93. Pacira Company Details 96
Table 94. Pacira Business Overview 97
Table 95. Pacira Nanoparticle Drug Delivery Systems Product 97
Table 96. Pacira Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million) 98
Table 97. Pacira Recent Development 98
Table 98. Luye Pharma Company Details 100
Table 99. Luye Pharma Business Overview 100
Table 100. Luye Pharma Nanoparticle Drug Delivery Systems Product 101
Table 101. Luye Pharma Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million) 101
Table 102. Leadiant Biosciences Company Details 102
Table 103. Leadiant Biosciences Business Overview 102
Table 104. Leadiant Biosciences Nanoparticle Drug Delivery Systems Product 103
Table 105. Leadiant Biosciences Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million) 103
Table 106. Leadiant Biosciences Recent Development 103
Table 107. Ipsen Company Details 104
Table 108. Ipsen Business Overview 105
Table 109. Ipsen Nanoparticle Drug Delivery Systems Product 105
Table 110. Ipsen Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million) 106
Table 111. Ipsen Recent Development 106
Table 112. Sayre Therapeutics Company Details 108
Table 113. Sayre Therapeutics Business Overview 108
Table 114. Sayre Therapeutics Nanoparticle Drug Delivery Systems Product 109
Table 115. Sayre Therapeutics Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million) 110
Table 116. Sayre Therapeutics Recent Development 110
Table 117. Jazz Company Details 111
Table 118. Jazz Business Overview 111
Table 119. Jazz Nanoparticle Drug Delivery Systems Product 112
Table 120. Jazz Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million) 112
Table 121. Jazz Recent Development 112
Table 122. Alnylam Company Details 114
Table 123. Alnylam Business Overview 114
Table 124. Alnylam Nanoparticle Drug Delivery Systems Product 115
Table 125. Alnylam Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million) 115
Table 126. Alnylam Recent Development 116
Table 127. Bausch Health Company Details 117
Table 128. Bausch Health Business Overview 118
Table 129. Bausch Health Nanoparticle Drug Delivery Systems Product 118
Table 130. Bausch Health Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million) 119
Table 131. Bausch Health Recent Development 119
Table 132. Acrotech Biopharma Company Details 120
Table 133. Acrotech Biopharma Business Overview 120
Table 134. Acrotech Biopharma Nanoparticle Drug Delivery Systems Product 121
Table 135. Acrotech Biopharma Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million) 121
Table 136. Acrotech Biopharma Recent Development 122
Table 137. Takeda Company Details 123
Table 138. Takeda Business Overview 123
Table 139. Takeda Nanoparticle Drug Delivery Systems Product 124
Table 140. Takeda Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million) 124
Table 141. Takeda Recent Development 124
Table 142. Chiesi Farmaceutici Company Details 126
Table 143. Chiesi Farmaceutici Business Overview 127
Table 144. Chiesi Farmaceutici Nanoparticle Drug Delivery Systems Product 127
Table 145. Chiesi Farmaceutici Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million) 127
Table 146. Gilead Sciences Company Details 128
Table 147. Gilead Sciences Business Overview 128
Table 148. Gilead Sciences Nanoparticle Drug Delivery Systems Product 129
Table 149. Gilead Sciences Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million) 129
Table 150. Gilead Sciences Recent Development 130
Table 151. Research Programs/Design for This Report 132
Table 152. Key Data Information from Secondary Sources 136
Table 153. Key Data Information from Primary Sources 137
List of Figures
Figure 1. Global Nanoparticle Drug Delivery Systems Market Share by Type: 2020 2
Figure 2. Global Nanoparticle Drug Delivery Systems Market Share by Type: 2027 3
Figure 3. Liposomes Drugs Features 4
Figure 4. Lipid Nanoparticle Drugs Features 5
Figure 5. Hospital Case Studies 7
Figure 6. Retail Pharmacy Case Studies 7
Figure 7. Nanoparticle Drug Delivery Systems Report Years Considered 8
Figure 8. Global Nanoparticle Drug Delivery Systems Market Size (US$ Million), Year-over-Year: 2016-2027 9
Figure 9. Global Nanoparticle Drug Delivery Systems Market Size, (US$ Million), 2016 VS 2021 VS 2027 10
Figure 10. Global Nanoparticle Drug Delivery Systems Market Share by Regions: 2020 11
Figure 11. Global Nanoparticle Drug Delivery Systems Market Share by Regions: 2027 11
Figure 12. Global Nanoparticle Drug Delivery Systems Market Share by Regions (2022-2027) 13
Figure 13. Global Nanoparticle Drug Delivery Systems Market Share by Players in 2020 23
Figure 14. The Top 5 Players Market Share by Nanoparticle Drug Delivery Systems Revenue in 2020 27
Figure 15. The Top 10 Players Market Share by Nanoparticle Drug Delivery Systems Revenue in 2020 28
Figure 16. Global Nanoparticle Drug Delivery Systems Revenue Market Share by Type (2016-2021) 33
Figure 17. Global Nanoparticle Drug Delivery Systems Revenue Market Share by Type (2022-2027) 34
Figure 18. North America Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) 37
Figure 19. North America Nanoparticle Drug Delivery Systems Market Share by Type (2016-2027) 38
Figure 20. North America Nanoparticle Drug Delivery Systems Market Share by Application (2016-2027) 40
Figure 21. North America Nanoparticle Drug Delivery Systems Market Share by Country (2016-2027) 41
Figure 22. United States Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) 42
Figure 23. Canada Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) 43
Figure 24. Mexico Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) 44
Figure 25. Europe Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) 45
Figure 26. Europe Nanoparticle Drug Delivery Systems Market Share by Type (2016-2027) 46
Figure 27. Europe Nanoparticle Drug Delivery Systems Market Share by Application (2016-2027) 48
Figure 28. Europe Nanoparticle Drug Delivery Systems Market Share by Country (2016-2027) 49
Figure 29. Germany Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) 50
Figure 30. France Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) 51
Figure 31. U.K. Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) 52
Figure 32. Italy Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) 53
Figure 33. Russia Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) 54
Figure 34. Asia-Pacific Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) 55
Figure 35. Asia-Pacific Nanoparticle Drug Delivery Systems Market Share by Type (2016-2027) 56
Figure 36. Asia-Pacific Nanoparticle Drug Delivery Systems Market Share by Application (2016-2027) 58
Figure 37. Asia-Pacific Nanoparticle Drug Delivery Systems Market Share by Region (2016-2027) 59
Figure 38. China Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) 60
Figure 39. Japan Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) 61
Figure 40. South Korea Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) 62
Figure 41. Southeast Asia Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) 63
Figure 42. India Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) 64
Figure 43. Australia Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) 65
Figure 44. South America Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) 66
Figure 45. South America Nanoparticle Drug Delivery Systems Market Share by Type (2016-2027) 67
Figure 46. South America Nanoparticle Drug Delivery Systems Market Share by Application (2016-2027) 69
Figure 47. South America Nanoparticle Drug Delivery Systems Market Share by Country 2020 70
Figure 48. Brazil Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) 71
Figure 49. Middle East & Africa Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) 72
Figure 50. Middle East & Africa Nanoparticle Drug Delivery Systems Market Share by Type (2016-2027) 73
Figure 51. Middle East & Africa Nanoparticle Drug Delivery Systems Market Share by Application (2016-2027) 75
Figure 52. Middle East & Africa Nanoparticle Drug Delivery Systems Market Share by Country 2020 76
Figure 53. Middle East Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) 77
Figure 54. Africa Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) 77
Figure 55. Bottom-up and Top-down Approaches for This Report 134
Figure 56. Data Triangulation 135
Figure 57. Key Executives Interviewed 137
  • Global and United States Cardiac Restoration System Market Report & Forecast 2022-2028
    Published: 17-May-2022        Price: US 4350 Onwards        Pages: 89
    Cardiac Restoration System market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Cardiac Restoration System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Cardiac Restoration System ma......
  • Global and United States Oncology Ablation Market Report & Forecast 2022-2028
    Published: 17-May-2022        Price: US 4350 Onwards        Pages: 97
    Oncology Ablation market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Oncology Ablation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Oncology Ablation market size by players, by Ty......
  • Global and United States Human Mesenchymal Stem Cells (hMSC) Market Report & Forecast 2022-2028
    Published: 17-May-2022        Price: US 4350 Onwards        Pages: 91
    Human Mesenchymal Stem Cells (hMSC) market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Human Mesenchymal Stem Cells (hMSC) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Human Mesen......
  • Global and United States Trans-Anal Irrigation (TAI) Market Report & Forecast 2022-2028
    Published: 17-May-2022        Price: US 4350 Onwards        Pages: 97
    Trans-Anal Irrigation (TAI) market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Trans-Anal Irrigation (TAI) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Trans-Anal Irrigation (TAI)......
  • Global and United States Rectal Irrigation Market Report & Forecast 2022-2028
    Published: 17-May-2022        Price: US 4350 Onwards        Pages: 96
    Rectal Irrigation market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Rectal Irrigation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Rectal Irrigation market size by players, by Ty......
  • Global and United States Bipolar Forceps Products Market Report & Forecast 2022-2028
    Published: 17-May-2022        Price: US 4350 Onwards        Pages: 127
    Bipolar Forceps Products market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Bipolar Forceps Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Bipolar Forceps Products market s......
  • Global and United States Bipolar Generator Market Report & Forecast 2022-2028
    Published: 17-May-2022        Price: US 4350 Onwards        Pages: 105
    Bipolar Generator market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Bipolar Generator market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Bipolar Generator market size by players, by Ty......
  • Global and United States Bipolar Forceps Generator Market Report & Forecast 2022-2028
    Published: 17-May-2022        Price: US 4350 Onwards        Pages: 100
    Bipolar Forceps Generator market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Bipolar Forceps Generator market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Bipolar Forceps Generator marke......
  • Global and United States Intra-body Ultradound Imaging and Sensing Market Report & Forecast 2022-2028
    Published: 17-May-2022        Price: US 4350 Onwards        Pages: 97
    Intra-body Ultradound Imaging and Sensing market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Intra-body Ultradound Imaging and Sensing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs